Previous tuberculosis infection associated with increased frequency of asthma and respiratory symptoms in a Nordic-Baltic multicentre population study.
Journal
ERJ open research
ISSN: 2312-0541
Titre abrégé: ERJ Open Res
Pays: England
ID NLM: 101671641
Informations de publication
Date de publication:
May 2023
May 2023
Historique:
received:
05
01
2023
accepted:
21
03
2023
medline:
25
5
2023
pubmed:
25
5
2023
entrez:
25
5
2023
Statut:
epublish
Résumé
Tuberculosis (TB) infection induces profound local and systemic, immunological and inflammatory changes that could influence the development of other respiratory diseases; however, the association between TB and asthma is only partly understood. Our objective was to study the association of TB with asthma and respiratory symptoms in a Nordic-Baltic population-based study. We included data from the Respiratory Health in Northern Europe (RHINE) study, in which information on general characteristics, TB infection, asthma and asthma-like symptoms were collected using standardised postal questionnaires. Asthma was defined based on asthma medication usage and/or asthma attacks 12 months prior to the study, and/or by a report of ≥three out of five respiratory symptoms in the last 12 months. Allergic/nonallergic asthma were defined as asthma with/without nasal allergy. The associations of TB with asthma outcomes were analysed using logistic regressions with adjustments for age, sex, smoking, body mass index and parental education. We included 8379 study participants aged 50-75 years, 61 of whom reported having had TB. In adjusted analyses, participants with a history of TB had higher odds of asthma (OR 1.99, 95% CI 1.13-3.47). The associations were consistent for nonallergic asthma (OR 2.17, 95% CI 1.16-4.07), but not for allergic asthma (OR 1.20, 95% CI 0.53-2.71). We found that in a large Northern European population-based cohort, persons with a history of TB infection more frequently had asthma and asthma symptoms. We speculate that this may reflect long-term effects of TB, including direct damage to the airways and lungs, as well as inflammatory responses.
Sections du résumé
Background
UNASSIGNED
Tuberculosis (TB) infection induces profound local and systemic, immunological and inflammatory changes that could influence the development of other respiratory diseases; however, the association between TB and asthma is only partly understood. Our objective was to study the association of TB with asthma and respiratory symptoms in a Nordic-Baltic population-based study.
Methods
UNASSIGNED
We included data from the Respiratory Health in Northern Europe (RHINE) study, in which information on general characteristics, TB infection, asthma and asthma-like symptoms were collected using standardised postal questionnaires. Asthma was defined based on asthma medication usage and/or asthma attacks 12 months prior to the study, and/or by a report of ≥three out of five respiratory symptoms in the last 12 months. Allergic/nonallergic asthma were defined as asthma with/without nasal allergy. The associations of TB with asthma outcomes were analysed using logistic regressions with adjustments for age, sex, smoking, body mass index and parental education.
Results
UNASSIGNED
We included 8379 study participants aged 50-75 years, 61 of whom reported having had TB. In adjusted analyses, participants with a history of TB had higher odds of asthma (OR 1.99, 95% CI 1.13-3.47). The associations were consistent for nonallergic asthma (OR 2.17, 95% CI 1.16-4.07), but not for allergic asthma (OR 1.20, 95% CI 0.53-2.71).
Conclusion
UNASSIGNED
We found that in a large Northern European population-based cohort, persons with a history of TB infection more frequently had asthma and asthma symptoms. We speculate that this may reflect long-term effects of TB, including direct damage to the airways and lungs, as well as inflammatory responses.
Identifiants
pubmed: 37228275
doi: 10.1183/23120541.00011-2023
pii: 00011-2023
pmc: PMC10204863
pii:
doi:
Types de publication
Journal Article
Langues
eng
Informations de copyright
Copyright ©The authors 2023.
Déclaration de conflit d'intérêts
Conflict of interest: The research team declares no conflict of interest.
Références
COPD. 2017 Apr;14(2):143-149
pubmed: 27880044
Int J Infect Dis. 2020 Mar;92S:S41-S45
pubmed: 32114203
Clin Exp Immunol. 2010 Apr;160(1):1-9
pubmed: 20415844
EClinicalMedicine. 2021 Feb 26;33:100752
pubmed: 33718847
BMC Pulm Med. 2014 Apr 16;14:63
pubmed: 24739530
Clin Rev Allergy Immunol. 2019 Apr;56(2):219-233
pubmed: 30206782
Eur Respir J. 2005 Jul;26(1):28-35
pubmed: 15994386
Can Respir J. 2021 Nov 24;2021:5434315
pubmed: 34868440
Immunology. 2004 Jul;112(3):352-63
pubmed: 15196202
Respiration. 2013;86(1):76-85
pubmed: 23652030
Clin Exp Allergy. 2006 Jan;36(1):70-6
pubmed: 16393268
PLoS Med. 2011 Mar;8(3):e1001012
pubmed: 21445325
J Allergy Clin Immunol. 1999 Dec;104(6):1211-4
pubmed: 10589003
Allergy. 2002 Jul;57(7):607-13
pubmed: 12100301
J Allergy Clin Immunol. 2003 Mar;111(3):541-9
pubmed: 12642835
Front Vet Sci. 2018 May 28;5:99
pubmed: 29892604
Chest. 2007 Jun;131(6):1817-24
pubmed: 17400690
Allergy. 2007 Feb;62(2):142-8
pubmed: 17298422
Eur Respir J. 2021 Dec 31;59(1):
pubmed: 34667060
Eur Respir J. 2015 Oct;46(4):1104-12
pubmed: 26113680
Clin Respir J. 2017 May;11(3):285-295
pubmed: 28268242
Eur Respir J. 1994 May;7(5):954-60
pubmed: 8050554
Respiration. 2021;100(8):751-763
pubmed: 33401266
Int Rev Immunol. 2019;38(4):172-179
pubmed: 31244354
Lung India. 2017 Mar-Apr;34(2):122-126
pubmed: 28360458
J Bras Pneumol. 2020 Mar 2;46(2):e20180198
pubmed: 32130330